{
  "url": "https://openlegislation.uk/medicines-advisory-bodies-no-2-regulations-2005/schedule-5/part-4/paragraph-3",
  "json_url": "https://openlegislation.uk/medicines-advisory-bodies-no-2-regulations-2005/schedule-5/part-4/paragraph-3.json",
  "legislation": "uksi/2005/2754",
  "legislation_title": "The Medicines (Advisory Bodies) (No. 2) Regulations 2005",
  "legislation_url": "https://openlegislation.uk/medicines-advisory-bodies-no-2-regulations-2005",
  "path": "schedule/5/part/4/paragraph/3",
  "kind": "paragraph",
  "number": "3",
  "heading": "Procedural provisions relating to the refusal or amendment of, or imposition of conditions relating to, clinical trial authorizations and the suspension or termination of clinical trials",
  "text": "(1) This paragraph applies where, before 30th October 2005—\n(a) a committee established under section 4 of the Act—\n(i) has considered written or oral representations of the sponsor or investigator; and\n(ii) has reported findings and advice to the licensing authority; and\n(b) the licensing authority have not made a decision under paragraph 1(3), (4), or (5) of Schedule 5 to the Clinical Trials Regulations.\n(2) The report of the committee referred to in sub-paragraph 1(a)(ii) shall be treated as the report of the appropriate committee under paragraph 1(6)(b) of Schedule 5 to those regulations.",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2005/2754/schedule/5/part/4/paragraph/3",
    "retrieved_at": "2026-10-29T04:49:26.804880+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}